comparemela.com

Latest Breaking News On - Kyle gano - Page 6 : comparemela.com

Neurocrine Biosciences (NBIX) Q4 2021 Earnings Call Transcript

Neurocrine Biosciences, Inc (NBIX) Q3 2021 Earnings Call Transcript

Neurocrine Biosciences Inc (NBIX) Q1 2021 Earnings Call Transcript

Neurocrine Biosciences Inc (NBIX) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Neurocrine Biosciences Inc (NASDAQ: NBIX) Popular Searches Operator Good day, everyone, and welcome to today s Neurocrine Biosciences Reports First Quarter Results. [Operator Instructions] It is now my pleasure to turn the conference over to Vice President of Investor Relations, Todd Tushla. Please go ahead.SPONSORED: 10 stocks we like better than Neurocrine Biosciences When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,

Neurocrine Biosciences Inc (NBIX) Q4 2020 Earnings Call Transcript

Operator Good day, everyone, and welcome to today s Neurocrine Biosciences Reports Fourth Quarter and Year-End 2020 Results. [Operator Instructions] [Operator Instructions] It is now my pleasure to turn the conference over to Vice President of Investor Relations, Todd Tushla. Todd Tushla Vice President of Investor Relations Thank you, Clorey. Good afternoon, everyone, and thank you for joining us on our fourth quarter and full year 2020 earnings call. On the call today is Kevin Gorman, our Chief Executive Officer; Matt Abernethy, our Chief Financial Officer; Eiry Roberts, our Chief Medical Officer; Eric Benevich, our Chief Commercial Officer; and Kyle Gano, our Chief Business Development and Strategy Officer.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.